jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 03, 2024

April. 03, 2024

jRCT1051240003

The Study of the treatment for Chronic Pain from knee osteoarthritis with Human Mesenchymal Stem Cell Conditioned Medium

A study of treatment of chronic pain with MSC-CM

Atsutomo Morishima

Omotesando Wellness Clinic

North Aoyama Building B1, 3-9-8 Kitaaoyama, Minato City, Tokyo 107-0061, Japan

+81-3-5962-6485

atsu5426@yahoo.co.jp

Atsutomo Morishima

Omotesando Wellness Clinic

North Aoyama Building B1, 3-9-8 Kitaaoyama, Minato City, Tokyo 107-0061, Japan

+81-3-5962-6485

atsu5426@yahoo.co.jp

Recruiting

April. 03, 2024

Observational

1. Individuals who is diagnosed as knee osteoarthritis.
2. Those for whom satisfactory pain relief effects were not observed with standard therapy.
3. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy for chronic pain due to concerns about side effects, and have been deemed suitable for chronic pain treatment with conditioned medium by a physician.

The patient selection criteria are as follows:
<Inclusion Criteria>
Patients meeting the following criteria will be considered eligible:

1. Individuals aged 18 and above.
2. Individuals with normal decision-making capacity.
3. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
4. Individuals for whom the attending physician has recognized the necessity of treatment.

<Exclusion Criteria>
Individuals meeting any of the following conditions will be excluded from the study:
1. Individuals without pain other than nociplastic pain.
2. Patients with a history or suspicion of dementia
3. Users of narcotics or stimulants.
4. Individuals deemed inappropriate by the attending physician.

18age old over
No limit

Both

Chronic Pain from knee osteoarthritis

D059350

1. Effect of pain on daily life
2. Pain intensity (Numerical Rating Scale; NRS)
3. Kellgren-Lawrence grade

subjective symptoms, etc.

Omotesando Wellness Clinic
Safety Assessment and Clinical Research in Japan
13-16 Sanjo Minamicho, Ashiya City, Hyogo

+81-797-22-5511

jpgh@ace.odn.ne.jp
Approval

Mar. 27, 2024

No

none